In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
Pictured: Alexander Rudensky
Announcement
Alexander Rudensky Appointed Immunology Program Chair

Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.
Pictured: Tunneling Nanotubes
Snapshot
Tunneling Nanotubes Connect Cancer Cells

Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.
Pictured: Ross Levine
In the Lab
Researchers Discover Why Some Leukemia Drugs Are Not Sufficiently Effective

Memorial Sloan Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.
Pictured: Natural Killer Cells & Cancer Cell
In the Lab
Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia

In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.
Pictured: Filippo Giancotti
In the Lab
Researchers Shed Light on Why Some Breast Cancers Spread to the Lungs

A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.
From the 2011 Annual Report
Computing the Shapes of Proteins from Genetic Information

Summary A team of researchers has made a breakthrough in solving a problem that has defied biologists for decades: How to compute a protein’s thre...
From the 2011 Annual Report
Novel Stem Cell Technique Shows Promise in Treating Disease

Cell replacement therapy seeks to restore function in the body by replacing cells that are lost due to disease or injury with new, healthy cells. One disease for which this type of therapy holds particular promise is the degenerative neurological disorder Parkinson’s disease, which is characterized by symptoms related to movement.
Pictured: Joan Massagué
In the Lab
Study Links Cancer’s Ability to Spread with Chemotherapy Resistance

A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
Pictured: Douglas Levine and Petar Jelinic
In the Lab
New Web Tool Helps Researchers Explore How the Genome Changes in Cancer

Memorial Sloan Kettering investigators hope their new web tool will improve the accessibility of large-scale genome-sequencing information for cancer researchers everywhere, and accelerate research and therapeutic discovery.
Pictured: Bayard Clarkson
Feature
Bayard Clarkson Receives 2012 Distinguished Service Award from the American Association for Cancer Research

Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR.